搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Arthroderma gypseum Neutral protease 2 homolog MGYG_03465 (MGYG_03465) CSB-YP516755DOO
CSB-EP516755DOO
CSB-BP516755DOO
CSB-MP516755DOO
CSB-EP516755DOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma gypseum Neutral protease 2 homolog MGYG_04094 (MGYG_04094) CSB-YP516756DOO
CSB-EP516756DOO
CSB-BP516756DOO
CSB-MP516756DOO
CSB-EP516756DOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma gypseum Subtilisin-like protease 2 (SUB2) CSB-YP516757DOO
CSB-EP516757DOO
CSB-BP516757DOO
CSB-MP516757DOO
CSB-EP516757DOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma gypseum Subtilisin-like protease 11 (SUB11) CSB-YP516758DOO
CSB-EP516758DOO
CSB-BP516758DOO
CSB-MP516758DOO
CSB-EP516758DOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptosphaeria maculans Probable Xaa-Pro aminopeptidase PEPP (PEPP), partial CSB-YP516759LOP
CSB-EP516759LOP
CSB-BP516759LOP
CSB-MP516759LOP
CSB-EP516759LOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptosphaeria maculans Putative metallocarboxypeptidase ECM14 (ECM14), partial CSB-YP516760LOP
CSB-EP516760LOP
CSB-BP516760LOP
CSB-MP516760LOP
CSB-EP516760LOP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leptosphaeria maculans High osmolarity signaling protein SHO1 (SHO1), partial CSB-YP516761LOP1
CSB-EP516761LOP1
CSB-BP516761LOP1
CSB-MP516761LOP1
CSB-EP516761LOP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sheep Testis- and ovary-specific PAZ domain-containing protein 1 (TOPAZ1), partial CSB-YP516762SH
CSB-EP516762SH
CSB-BP516762SH
CSB-MP516762SH
CSB-EP516762SH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma gypseum Probable zinc metalloprotease MGYG_01137 (MGYG_01137), partial CSB-YP516763DOO
CSB-EP516763DOO
CSB-BP516763DOO
CSB-MP516763DOO
CSB-EP516763DOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma gypseum Methionine aminopeptidase 2 homolog MGYG_01859 (MGYG_01859) CSB-YP516764DOO
CSB-EP516764DOO
CSB-BP516764DOO
CSB-MP516764DOO
CSB-EP516764DOO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Ankyrin repeat domain-containing protein 65 (ANKRD65) CSB-YP516765HU
CSB-EP516765HU
CSB-BP516765HU
CSB-MP516765HU
CSB-EP516765HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neisseria meningitidis serogroup B / serotype 15 Adenylate kinase (adk) CSB-YP516766NGH
CSB-EP516766NGH
CSB-BP516766NGH
CSB-MP516766NGH
CSB-EP516766NGH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Intrasporangium calvum Tyrosine phenol-lyase (tpl) CSB-YP516767IMZ
CSB-EP516767IMZ
CSB-BP516767IMZ
CSB-MP516767IMZ
CSB-EP516767IMZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfurispirillum indicum Protein translocase subunit SecF (secF), partial CSB-YP516768DJS1
CSB-EP516768DJS1
CSB-BP516768DJS1
CSB-MP516768DJS1
CSB-EP516768DJS1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesobuthus martensii Neurotoxin BmK AGP-SYPU1 (AGP-SYPU1) CSB-YP516769MRE
CSB-EP516769MRE
CSB-BP516769MRE
CSB-MP516769MRE
CSB-EP516769MRE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhopalurus junceus Putative beta-neurotoxin RjAa12 CSB-YP516770RMG
CSB-EP516770RMG
CSB-BP516770RMG
CSB-MP516770RMG
CSB-EP516770RMG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhopalurus junceus Putative beta-neurotoxin RjAa15f CSB-YP516771RMG
CSB-EP516771RMG
CSB-BP516771RMG
CSB-MP516771RMG
CSB-EP516771RMG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Serine protease 44 (PRSS44) CSB-YP516772HU
CSB-EP516772HU
CSB-BP516772HU
CSB-MP516772HU
CSB-EP516772HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Tudor domain-containing protein 7B (tdrd7b), partial CSB-YP516773DIL
CSB-EP516773DIL
CSB-BP516773DIL
CSB-MP516773DIL
CSB-EP516773DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Topoisomerase I damage affected protein 11 (TDA11) CSB-YP516774SVI
CSB-EP516774SVI
CSB-BP516774SVI
CSB-MP516774SVI
CSB-EP516774SVI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>